Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
I have not seen bilingual recaps at other clinics
To navigate this evolving landscape, employers should consider these actions: Engage with PBMs to clarify the formulary placement of oral Wegovy and understand how net pricing compares to the injectable version
IN THIS EPISODE - Taras lifelong experience with obesity, dieting, and weight stigma - How a radio ad and a clinical-trial opening changed the course of her life - What it was like to join an early tirzepatide trial with only a 25% chance of receiving the medication - The role of nutrition support, movement, and gradual behavior change - Losing 132 pounds in 18 monthsand what happened when the trial ended - Navigating medication access, shortages, judgment, and compounded medication - Why the scale and clothing sizes can become a new kind of obsession - Recognizing when continued weight loss was no longer healthy - What long-term maintenance looks like after a major weight change - Using medication as one tool in a broader, ongoing relationship with health ABOUT THE GUEST Tara Rothenhoefer is a wife, mom, and grandma who, after a lifelong battle with obesity, joined a clinical trial for tirzepatide in 2020 that led to her 222-pound weight loss
Other downsides are that these meds are currently subcutaneous injections, although oral agents in this class are on the horizon
The Medicines and Healthcare products Regulatory Agency (MHRA) said the trend had only just emerged, leading them to conduct the largest single seizure of trafficked weight-loss drugs ever recorded by any global law enforcement agency
Same time, every day
US$ 29.75
US$ 28.37
US$ 28.14
US$ 29.19
US$ 25.04
